Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.

Lu, Hezhe; Liu, Shujing; Zhang, Gao; Wu, Bin; Zhu, Yueyao; Frederick, Dennie T; Hu, Yi; Zhong, Wenqun et al. · Nature · 2019

editorial · Level V

Where this comes from

Record sourced from PubMed, PMID 30532003.
Also identified by DOI 10.1038/s41586-018-0814-7.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

In this Letter, two relevant references were omitted; see the accompanying Amendment for details. The original Letter has not been corrected.